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Heart failure (HF) is a global public health menace which 
is associated with increased hospitalization, morbidity, 
mortality and high economic costs.1 However, HF which has 
ischemic heart disease as a common underlying disease, is a 
preventable condition. Cardiorespiratory fitness (CRF) is an 
index of habitual physical activity levels and is considered the 
gold standard for aerobic exercise capacity. Cardiorespiratory 
fitness, an important component of physical fitness and 
directly measured by peak oxygen uptake (pVO2), and 
ventilatory efficiency slope (VE/VCO2 slope), has been 
identified as one of the most important predictors of health 
outcomes and survival.2 We have previously reported that 
directly assessed pVO2 is strongly, independently and 
inversely related to a lowered risk of cardiometabolic 
conditions such as HF,2,3 atrial fibrillation,3,4 ventricular 
fibrillation,5 diabetes6 as well as mortality from cardiovascular 
diseases (CVDs).7,8 Our recent population-based study based 
on UK Biobank suggests that CRF is a strong risk indicator for 
mortality and addition of CRF to a conventional risk factor 
score improved the overall discrimination of mortality risk 
and, more importantly, the predictive value of CRF varied 
across levels of some relevant risk factors, including age, sex, 
and smoking.8 This is an indicator of the potential of CRF to 
be a valuable risk assessment tool in clinical practice.
It is well-known that obesity, as measured by body mass index 
(BMI), is related to the development of cardiovascular outcomes. 
However, the combined effect of obesity and CRF on the risk 
of future HF still requires further study. It is of clinical relevance 
to understand if CRF attenuates the association of obesity with 
later risk of HF due to other underlying CVDs.9 The majority 
of previous studies on higher BMI, other obesity parameters, 
and HF risk have not taken into account the differences in CRF 
levels. Though high BMI is a risk factor for HF, there are findings 
of a non-linear relationship between BMI and CVD outcomes 
in HF patients which indicates an unusual relationship. In 
patients with established HF, accumulating evidence suggests 
that overweight and obese (higher BMI) individuals have 
improved survival compared to those with normal BMI, a 
known concept which has been called the “obesity paradox” 
or “reverse epidemiology”.10 Some mechanisms have been 
proposed to explain the HF obesity paradox which includes 
HF therapy being more effective in obese patients. It has been 
reported that CRF might play also play a role by either mitigating 
or negating the “obesity paradox”.10,11
There is limited evidence on the association and interactions 
between CRF, BMI, HF and HF outcomes. This was the rationale 
for the new study by Moreira et al. published in the recent 
issue of the journal, which aimed to investigate the impact 
of exercise tolerance and cardiorespiratory capacity on the 
obesity paradox among HF patients with low ejection fraction.12 
All patients referred to the Heart Failure Clinics underwent 
clinical evaluation with collection of laboratory, electro- and 
echocardiographic, and cardiopulmonary exercise test data. 
A maximal symptom-limited treadmill cardiopulmonary 
exercise test was performed using the modified Bruce protocol 
(GE Marquette Series 2000 treadmill). Minute ventilation, 
oxygen uptake, and carbon dioxide production were acquired 
using a breath-by-breath gas analyzer. A total of 282 HF patients 
were included (75.5% male) with a mean age of 53.7 years and 
BMI of 28.6 kg/m2. Patients were followed-up for 60 months for 
a combined composite endpoint comprising of cardiac death, 
urgent heart transplant, or need for mechanical circulatory 
support.12 Interestingly, patients with higher BMI had higher 
LVEF but lower ventilatory efficiency (VE/VCO2) slope.
12 
Association analysis showed BMI, VE/VCO2 slope and pVO2 
to be each an indicator of the primary outcome. However, the 
association between BMI and outcome was attenuated to null 
when patients were grouped into low and high CRF (based on 
VE/VCO2) and after controlling for VE/VCO2 or pVO2.
Consistent with findings of this study, Chase et al. have 
earlier demonstrated that VE/VCO2 slope maintained its 
prognostic value irrespective of BMI in patients with HF.13 
However, when either VE/VCO2 slope or pVO2 were taken 
into account in their analyses, the association between BMI 
and cardiac outcomes were not significant. Moreover, when 
the patients were grouped and analyzed according to their 
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Given that the absolute risk of adverse CVD outcomes 
depends largely on age, employing a single relative metric 
cannot allow quantification of absolute risk differences 
across increasing ages with different BMI levels. Zaccardi et 
al.14 recently suggested a new approach to evaluate the 
interplay were to estimate residual life expectancy across 
CRF levels and BMI.14 Based on the large UK Biobank cohort 
including 474,919 participants, the authors demonstrated 
that participants with a brisk walking pace have a longer life 
expectancy across the spectrum of BMI and other fatness 
measures, providing additional data evidence that walking 
pace, as a marker of fitness level, is an easily available 
indicator of health status. 
The strengths of the current study include the use of a 
clinically relevant sample based on high-risk HF patients and 
the assessment of CRF measures using reliable respiratory 
gas analysis, which is a more objective and quantitative 
assessment method for CRF. Several limitations include (i) the 
small sample size; (ii) inability to adjust for many potential 
confounders; (iii) lack of data on medications, biomarkers, 
and physical activity patterns during follow-up, which could 
have at least partly influenced CRF and BMI levels; (iv) lack of 
formal risk prediction analyses as measures of association are 
insufficient for making clinical judgments about the prognostic 
relevance of an exposure; and (v) the potential for regression 
dilution given the absence of repeat measurements of CRF, 
given the potential for changes in CRF levels due to errors 
in measurements and changes in the clinical course of the 
disease. In our reproducibility substudies of CRF measurements 
within the Kuopio Ischemic Heart Disease (KIHD) prospective 
cohort study, we have demonstrated a high within-person 
variability in CRF levels measured many years apart (regression 
dilution ratio=0.58);15 which suggests that analyses using only 
single baseline measurements of CRF could underestimate 
associations with outcomes. Overall, these new findings 
highlight the fact that an “obesity paradox” exists in HF patients 
and there is an interplay between obesity, CRF and outcomes in 
HF. Cardiorespiratory fitness as measured by VE/VCO2 or pVO2 
appeared to negate the obesity paradox.12 
CRF is influenced by genetic and environmental factors; 
approximately 50 % of the variation in CRF has been attributed 
to heritable factors, with the contribution of inherited factors 
to the response of CRF to physical activity and exercise 
training.7,8,11 It also depends on several factors such as baseline 
health and fitness status, type, duration, and intensity of PA. 
The level of CRF is also an indicator of a chain of multiple 
physiological processes that include: pulmonary ventilation 
and vascular function, right and left ventricular function, the 
capacity of the vasculature to efficiently transport blood from 
the heart to other organs matching their oxygen requirements, 
the ability of the muscle cells to use the oxygen and essential 
nutrients, and the ability to activate all necessary muscle fibres 
needed for body movement.11 Left ventricular stroke volume, 
maximal heart rate, and arteriovenous oxygen difference 
at exercise have essentially determined CRF levels. Left 
ventricular function is a key measure of HF and CRF level 
may reflect LV function. As CRF is related to the integration 
of human body function under physiological stress conditions, 
it can be employed as a very accurate indicator of the risk for 
HF, reflecting whole body functional status among patients 
with existing HF. Given the central role normal cardiac 
function plays in defining maximal aerobic capacity, disease, 
or dysfunction that detrimentally affects cardiac output 
will also compromise maximal VO2. High-intensity aerobic 
exercise training is safe and effective in improving functional 
capacity in many patient populations with cardiac conditions.11 
Participation in a long-term aerobic exercise training program 
produces a host of positive morphological and physiological 
cardiovascular adaptations in apparently healthy individuals, 
irrespective of age and sex. Commonly reported morphological 
adaptations associated with regular aerobic exercise training is 
left ventricular dilation (ie, increased end-diastolic diameter) 
and hypertrophy (ie, increased wall thickness), referred to as 
exercise training-induced cardiac remodelling.16
The current findings throw more light on a possible 
interaction between CRF, obesity and outcomes in HF. 
However, given the limitations of small sample size and 
inability to adjust for relevant covariates, these observational 
study findings need caution when being interpreted. 
Findings add to the minefield of accumulating evidence that 
CRF (using peak VO2 and measures of ventilatory efficiency) 
is a clinically useful tool in HF risk assessment. High levels of 
CRF can be achieved through regular physical activity and 
this should be promoted extensively via population wide 
approaches. The health benefits associated with regular 
physical activity, which includes aerobic and strength 
training components, cannot be overemphasized.11,14,16 
Efforts to improve CRF with a healthy body weight could 
become a standard part of clinical encounters for the 
treatment of HF with low ejection fraction.
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